Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, January 10, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
Aditum Bio Announces Formation of Third Company, Anteris Bio Anteris Bio Aimed at Treating Renal Diseases
Life Sciences Times
-
December 15, 2020
0
Biotech
FDA grants IO Biotech products breakthrough therapy designation
Life Sciences Times
-
December 15, 2020
0
Biotech
Massachusetts Biotech Council President and CEO Robert Coughlin to Step Down
Life Sciences Times
-
December 14, 2020
0
Venture Capital
Robotics Specialist German Bionic Receives US $20 Million in Series A Financing
Life Sciences Times
-
December 14, 2020
0
Medtech
Heartseed Named “Healthcare Company of the Year 2020” by Healthcare Insights Magazine in the MedTech Category for Making a Crucial Impact in Healthcare
Life Sciences Times
-
December 14, 2020
0
Pharma
Agilent Receives Multiple Innovation Awards
Life Sciences Times
-
December 14, 2020
0
Real Estate
Blackstone Real Estate Acquires Premier Lab Office Portfolio from Brookfield Fund
Life Sciences Times
-
December 14, 2020
0
Pharma
908 Devices Announces Launch of Initial Public Offering
Life Sciences Times
-
December 14, 2020
0
Biotech
EdiGene Appointments Bo Zhang as Head of US Subsidiary and Kehua Fan Head of Business Development
Life Sciences Times
-
December 14, 2020
0
Real Estate
Colliers International’s Recent Sale Assignment Demonstrates Momentum of Life Science Market
Life Sciences Times
-
December 14, 2020
0
1
...
777
778
779
...
782
Page 778 of 782
Most Popular
Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases
January 9, 2026
GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform
January 9, 2026
MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial
January 9, 2026
Prolytix Expands Thrombosis and Hemostasis Testing Capabilities With HRL Assay Acquisition
January 9, 2026
Load more
Recent Comments
Recent Comments